BCL2 Lymphoma Classification Test | Lahalak Platform
A specialized histological examination measuring BCL2 protein levels responsible for cell death resistance, helping diagnose and classify lymphomas and determine the disease's aggressiveness.
Scientific name: Immunohistochemistry: BCL2 Test
Immunohistochemistry is an immunochemical test used to detect the expression of the BCL2 (B-cell lymphoma 2) protein in cells. BCL2 acts as an inhibitor of apoptosis (programmed cell death), and its increased expression prevents cell death and allows abnormal cell survival. This test is primarily used in the diagnosis and classification of lymphoma...
Service type
Immunohistochemistry (IHC) Test
Duration
15-20 minutes
Fasting
Fasting is not required
Included Services
- A comprehensive examination of the core immunological marker panel for the diagnosis of lymphomas (including BCL2, CD20, CD3, Ki-67, and others).
- Check for additional subclassification markers as needed (e.g., CD5, CD10, CD23, Cyclin D1).
- Consult a pathologist specializing in hematological malignancies for an interpretation of the overall results.
- Personal support services from Lahalak
Medical Service Information
Conditions & Notices
- It requires the submission of a complete tissue block (paraffin block) of the lymphoid or tumor biopsy specimen.
- It is necessary to attach the initial pathology report (initial microscopic diagnosis) and the complete clinical patient file.
- The patient does not need to fast, as the tissue sample is stable.
- Due to the complexity of the package, please contact the laboratory in advance to ensure the adequacy of the tissue provided.
Medical services you might also like
